{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:51:02Z","timestamp":1790743862011,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.rdc.2013.06.001","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T21:35:45Z","timestamp":1379626545000},"page":"877-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Developments in the Classification and Treatment of the Juvenile Idiopathic Inflammatory Myopathies"],"prefix":"10.1016","volume":"39","author":[{"given":"Lisa G.","family":"Rider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olcay Y.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2013.06.001_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis. Parts 1 and 2","volume":"292","author":"Bohan","year":"1975","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.06.001_bib2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","article-title":"An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)","volume":"45","author":"Brown","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.06.001_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-857X(05)70350-1","article-title":"Classification and treatment of the juvenile idiopathic inflammatory myopathies","volume":"23","author":"Rider","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2013.06.001_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2010.1977","article-title":"Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies","volume":"305","author":"Rider","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2013.06.001_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","article-title":"The clinical phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.rdc.2013.06.001_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/mus.23854","article-title":"Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies: a review","author":"Mohassel","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2013.06.001_bib7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The juvenile dermatomyositis national registry and repository (UK and Ireland)\u2013clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.06.001_bib8","first-page":"1031","article-title":"A\u00a0Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases","volume":"27","author":"Sato","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib9","first-page":"117","article-title":"Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis","volume":"29","author":"Guseinova","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1590\/S0021-75572008000100012","article-title":"Risk factors associated with calcinosis of juvenile dermatomyositis","volume":"84","author":"Sallum","year":"2008","journal-title":"J\u00a0Pediatr (Rio J)"},{"key":"10.1016\/j.rdc.2013.06.001_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","article-title":"Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity","volume":"87","author":"Bingham","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2013.06.001_bib12","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/rheumatology\/kem265","article-title":"HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap","volume":"46","author":"Wedderburn","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2013.06.001_bib13","first-page":"S127","article-title":"Illness features associated with an increased risk of mortality in children with juvenile idiopathic inflammatory myopathies","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pediatrneurol.2011.01.018","article-title":"Idiopathic inflammatory myopathies in childhood: a brief review of 27 cases","volume":"45","author":"Lorenzoni","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.rdc.2013.06.001_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2133.2007.08055.x","article-title":"A\u00a0systematic review of juvenile-onset clinically amyopathic dermatomyositis","volume":"157","author":"Gerami","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00124743-200106000-00012","article-title":"Amyopathic dermatomyositis in children: a diagnostic and therapeutic dilemma","volume":"7","author":"Mukamel","year":"2001","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib17","first-page":"2031","article-title":"Juvenile amyopathic dermatomyositis: results of a case finding descriptive survey","volume":"27","author":"Plamondon","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11910-012-0321-4","article-title":"Inclusion body myositis","volume":"13","author":"Dimachkie","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.rdc.2013.06.001_bib19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","article-title":"The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis","volume":"33","author":"Limaye","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2013.06.001_bib20","doi-asserted-by":"crossref","first-page":"e1293","DOI":"10.1542\/peds.2010-2115","article-title":"Ovarian teratoma mimicking features of juvenile dermatomyositis in a child","volume":"128","author":"Ibarra","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.rdc.2013.06.001_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","article-title":"Juvenile dermatomyositis as a paraneoplastic phenomenon: an update","volume":"32","author":"Morris","year":"2010","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.rdc.2013.06.001_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/PAS.0b013e31819e63fe","article-title":"Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process","volume":"33","author":"Auerbach","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rdc.2013.06.001_bib23","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/1097-4598(200010)23:10<1569::AID-MUS14>3.0.CO;2-M","article-title":"Clinical and pathologic features of focal myositis","volume":"23","author":"Smith","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2013.06.001_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11882-012-0319-7","article-title":"Ocular myositis","volume":"13","author":"Fraser","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.rdc.2013.06.001_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11882-009-0045-y","article-title":"Orbital myositis: diagnosis and management","volume":"9","author":"Costa","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.rdc.2013.06.001_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2011.07.004","article-title":"IgG4-related systemic disease as a cause of \u201cidiopathic\u201d orbital inflammation, including orbital myositis, and trigeminal nerve involvement","volume":"57","author":"Wallace","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.rdc.2013.06.001_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00381-011-1613-8","article-title":"Orbital myositis associated with focal active colitis in a teenage girl","volume":"28","author":"Kondolot","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.rdc.2013.06.001_bib28","first-page":"927","article-title":"Autoantibody to signal recognition particle in African American girls with juvenile polymyositis","volume":"35","author":"Rouster-Stevens","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12016-010-8212-4","article-title":"Macrophagic myofasciitis a vaccine (alum) autoimmune-related disease","volume":"41","author":"Israeli","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.rdc.2013.06.001_bib30","first-page":"172","article-title":"Pediatric macrophagic myofasciitis associated with motor delay","volume":"25","author":"Gruis","year":"2006","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.rdc.2013.06.001_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pediatrneurol.2005.05.024","article-title":"Macrophagic myofasciitis in childhood: a controversial entity","volume":"33","author":"Rivas","year":"2005","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.rdc.2013.06.001_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0883073807312370","article-title":"Macrophagic myofasciitis in children is a localized reaction to vaccination","volume":"23","author":"Lach","year":"2008","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.rdc.2013.06.001_bib33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00002281-199811000-00002","article-title":"Eosinophilic myopathic syndromes","volume":"10","author":"Pickering","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.7.4.421","article-title":"Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations","volume":"7","author":"Dourmishev","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.rdc.2013.06.001_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ana.20900","article-title":"Calpainopathy and eosinophilic myositis","volume":"59","author":"Brown","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2013.06.001_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nmd.2008.11.010","article-title":"Eosinophilic myositis as presenting symptom in gamma-sarcoglycanopathy","volume":"19","author":"Baumeister","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.rdc.2013.06.001_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.prp.2008.03.006","article-title":"Myopathology of non-infectious inflammatory myopathies - the current status","volume":"204","author":"Hewer","year":"2008","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.rdc.2013.06.001_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mus.20683","article-title":"Granulomatous myositis: a clinical study of thirteen cases","volume":"35","author":"Le","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2013.06.001_bib39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1309\/AJCPLEPS44PJHDPP","article-title":"Pseudosarcomatous fasciitis and myositis: diagnosis by fine-needle aspiration cytology","volume":"132","author":"Wong","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rdc.2013.06.001_bib40","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00256-011-1274-4","article-title":"Proliferative myositis: expanding the differential diagnosis of a soft tissue mass in infancy","volume":"40","author":"Talbert","year":"2011","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.rdc.2013.06.001_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/rheumatology\/keg025","article-title":"Polymyositis as a manifestation of chronic graft-versus-host disease","volume":"42","author":"Stevens","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.06.001_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.410400515","article-title":"Congenital muscular dystrophy with\u00a0primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy","volume":"40","author":"Pegoraro","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2013.06.001_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.06.001_bib44","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.23299","article-title":"Persistent association of nail fold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis","volume":"58","author":"Christen-Zaech","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/art.22993","article-title":"Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients","volume":"57","author":"Miles","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib47","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/art.24571","article-title":"Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment","volume":"60","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib48","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/ar2841","article-title":"Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies","volume":"11","author":"Eidelman","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2013.06.001_bib49","first-page":"126","article-title":"Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients","volume":"30","author":"Aikawa","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/acr.22088","article-title":"Clinical and Laboratory Features Distinguishing Juvenile Polymyositis and Muscular Dystrophy","author":"Mamyrova","year":"2013","journal-title":"Arthritis Care and Reseach"},{"key":"10.1016\/j.rdc.2013.06.001_bib51","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A\u00a0systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1442-200X.2009.02946.x","article-title":"Juvenile amyopathic dermatomyositis complicated by progressive interstitial pneumonia","volume":"52","author":"Abe","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1016\/j.rdc.2013.06.001_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/01913120601169550","article-title":"Macrophagic myofasciitis in childhood: the role of scanning electron microscopy\/energy-dispersive spectroscopy for diagnosis","volume":"31","author":"Kalil","year":"2007","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"10.1016\/j.rdc.2013.06.001_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.rdc.2013.06.001_bib55","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.06.001_bib56","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis","volume":"64","author":"Trallero-Araguas","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib57","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib58","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","article-title":"Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein","volume":"36","author":"Espada","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2010.11.033","article-title":"Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis","volume":"158","author":"Kobayashi","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2013.06.001_bib60","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3899\/jrheum.101220","article-title":"Anti-CADM-140 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and cardiac involvement","volume":"38","author":"Sakurai","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib61","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.06.001_bib62","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","article-title":"Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody","volume":"64","author":"Cao","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.06.001_bib63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","article-title":"Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort","volume":"72","author":"Fujimoto","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.06.001_bib65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","article-title":"Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort","volume":"384","author":"Tarricone","year":"2012","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.rdc.2013.06.001_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","article-title":"Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients","volume":"77","author":"Vancsa","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rdc.2013.06.001_bib67","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2013.06.001_bib68","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib69","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2013.06.001_bib70","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","article-title":"Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease","volume":"91","author":"Rigolet","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2013.06.001_bib72","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A\u00a0novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib73","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","article-title":"Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay","volume":"49","author":"Ghirardello","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 11","key":"10.1016\/j.rdc.2013.06.001_bib74","first-page":"S118","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.06.001_bib75","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/art.20349","article-title":"International consensus on preliminary definitions of improvement in adult and juvenile myositis","volume":"50","author":"Rider","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib76","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/acr.20280","article-title":"The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.06.001_bib77","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2013.06.001_bib78","first-page":"S1042","article-title":"A\u00a0randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate","volume":"64","author":"Ruperto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.06.001_bib80","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.06.001_bib81","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/art.23829","article-title":"The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis","volume":"59","author":"Seshadri","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib82","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.23341","article-title":"Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis","volume":"59","author":"Rouster-Stevens","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib83","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib84","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1136\/ard.2011.153718","article-title":"Efficacy of intravenous Ig therapy in juvenile dermatomyositis","volume":"70","author":"Lam","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.06.001_bib85","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00296-010-1653-5","article-title":"Mycophenolate mofetil in juvenile dermatomyositis: a case series","volume":"32","author":"Dagher","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2013.06.001_bib86","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","article-title":"Treatment of antisynthetase-associated interstitial lung disease with tacrolimus","volume":"52","author":"Wilkes","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib87","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10067-008-0973-2","article-title":"Treatment of refractory juvenile dermatomyositis with tacrolimus","volume":"27","author":"Hassan","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/keh082","article-title":"Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety","volume":"43","author":"Riley","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2013.06.001_bib89","first-page":"S130","article-title":"Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland [abstract]","volume":"64","author":"Moraitis","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2013.06.001_bib90","first-page":"S325","article-title":"Effect of B cell depletion therapy with rituximab on myositis associated autoantibody levels in idiopathic inflammatory myopathy","volume":"64","author":"Aggarwal","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib91","first-page":"1009","article-title":"Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature","volume":"27","author":"Rios","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib92","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/art.22856","article-title":"Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients","volume":"56","author":"Cooper","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib93","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A\u00a0pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib94","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2013.06.001_bib95","first-page":"S795","article-title":"Juvenile Dermatomyositis Research Group. Effectiveness of anti-tumor necrosis factor- agents in the treatment of refractory juvenile dermatomyositis","volume":"63","author":"Boulter","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib96","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/BOR.0b013e328358ac72","article-title":"Therapeutic advances in myositis","volume":"24","author":"Aggarwal","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib97","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rdc.2011.01.002","article-title":"Polymyositis and dermatomyositis: pathophysiology","volume":"37","author":"Nagaraju","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2013.06.001_bib98","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib99","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","article-title":"Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis","volume":"7","author":"Robinson","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib100","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3899\/jrheum.090953","article-title":"Treatment approaches to juvenile dermatomyositis (JDM) across North America: the Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey","volume":"37","author":"Stringer","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib101","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1002\/art.30475","article-title":"Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study","volume":"63","author":"Hasija","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib102","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A\u00a0controlled trial of high-does intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.06.001_bib103","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1542\/peds.2007-1218","article-title":"Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content","volume":"121","author":"Manlhiot","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.rdc.2013.06.001_bib104","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/DDDT.S33110","article-title":"Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series","volume":"6","author":"Levine","year":"2012","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.rdc.2013.06.001_bib105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1525-1470.2011.01501.x","article-title":"Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use","volume":"28","author":"Chiu","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/art.37758","article-title":"The efficacy of rituximab in refractory myositis: the jury is still out","volume":"65","author":"de Visser","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib107","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.34468","article-title":"Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies","volume":"64","author":"Molloy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib108","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/art.24039","article-title":"Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis","volume":"58","author":"Mamyrova","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Suppl 9","key":"10.1016\/j.rdc.2013.06.001_bib109","first-page":"S923","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of infliximab in patients with polymyositis and dermatomyositis","volume":"58","author":"Coyle","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","article-title":"Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations","volume":"50","author":"Hengstman","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.rdc.2013.06.001_bib111","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000114036","article-title":"Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate","volume":"59","author":"Hengstman","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.rdc.2013.06.001_bib112","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A\u00a0high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 9","key":"10.1016\/j.rdc.2013.06.001_bib113","first-page":"S306","article-title":"Use of etanercept in chronic juvenile dermatomyositis (JDM)","volume":"46","author":"Miller","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib114","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","article-title":"A\u00a0randomized, pilot trial of etanercept in dermatomyositis","volume":"70","author":"Muscle Study Group","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2013.06.001_bib115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","volume":"146","author":"Klein","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib116","article-title":"Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up","author":"Zong","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.06.001_bib117","article-title":"A\u00a0phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients","author":"Higgs","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.06.001_bib118","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","article-title":"Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis","volume":"160","author":"Arabshahi","year":"2012","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2013.06.001_bib119","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/rheumatology\/ker152","article-title":"Therapeutic effect of tocilizumab on two patients with polymyositis","volume":"50","author":"Narazaki","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.06.001_bib120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-011-9533-7","article-title":"Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis","volume":"31","author":"Reiff","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.rdc.2013.06.001_bib121","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","article-title":"Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis","volume":"132","author":"Dalakas","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.rdc.2013.06.001_bib122","first-page":"809","article-title":"Treatment of refractory rheumatism among preschool children with autologous peripheral blood hematopoietic stem cell transplantation","volume":"45","author":"Wu","year":"2007","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.rdc.2013.06.001_bib123","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03009740903096622","article-title":"Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis","volume":"39","author":"Holzer","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2013.06.001_bib124","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/art.37985","article-title":"Childhood Myositis Heterogeneity Collaborative Study Group. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis","volume":"65","author":"Shah","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib125","doi-asserted-by":"crossref","first-page":"828","DOI":"10.5604\/17322693.1019532","article-title":"Bystander effect induced by UV radiation; why should we be interested?","volume":"66","author":"Widel","year":"2012","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"10.1016\/j.rdc.2013.06.001_bib126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/jid.2012.234","article-title":"Reflections on the field of photoimmunology","volume":"133","author":"Kripke","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib127","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/10899380-000000000-00000","article-title":"Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management","volume":"12","author":"Walling","year":"2010","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.rdc.2013.06.001_bib128","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2010.01.005","article-title":"Sunscreens: an overview and update","volume":"64","author":"Sambandan","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1529-8019.2009.01289.x","article-title":"Photoprotection: a review of the current and future technologies","volume":"23","author":"Wang","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rdc.2013.06.001_bib130","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/art.27529","article-title":"Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells","volume":"62","author":"Shrestha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2013.01.001","article-title":"Multifaceted effects of hydroxychloroquine in human disease","author":"Olsen","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib132","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1346-8138.2010.01167.x","article-title":"Successful treatment of intractable ulceration associated with dermatomyositis by debridement and the skin implantation of an artificial dermis sheet","volume":"38","author":"Matsuda","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib133","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/BOR.0b013e32834ff5cd","article-title":"Soft tissue and subcutaneous calcification in connective tissue diseases","volume":"24","author":"Chander","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib134","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1529-8019.2012.01492.x","article-title":"Calcinosis cutis in autoimmune connective tissue diseases","volume":"25","author":"Gutierrez","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rdc.2013.06.001_bib135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/kes232","article-title":"Aerobic fitness after JDM\u2013a long-term follow-up study","volume":"52","author":"Mathiesen","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.06.001_bib136","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/art.21332","article-title":"Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis","volume":"53","author":"Maillard","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.06.001_bib137","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/BOR.0b013e32834f19f5","article-title":"Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies","volume":"24","author":"Alexanderson","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2013.06.001_bib138","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/acr.21684","article-title":"Exercise training in juvenile dermatomyositis","volume":"64","author":"Omori","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:52Z","timestamp":1760181232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":138,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0889857X13000689"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.06.001","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developments in the Classification and Treatment of the Juvenile Idiopathic Inflammatory Myopathies","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}